| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 342,119 | 149,624 | ||
| Short-term investments | 691,382 | 761,901 | ||
| Restricted cash | 2,519 | 2,509 | ||
| Trade receivables, net | 85,230 | 89,915 | ||
| Receivables and prepaid expenses | 39,500 | 39,139 | ||
| Inventories | 39,104 | 40,211 | ||
| Total current assets | 1,199,854 | 1,083,299 | ||
| Property and equipment, net | 79,976 | 80,333 | ||
| Field equipment, net | 20,549 | 18,591 | ||
| Right-of-use assets | 48,402 | 48,089 | ||
| Other long-term assets | 12,413 | 15,563 | ||
| Total long-term assets | 161,340 | 162,576 | ||
| Total assets | 1,361,194 | 1,245,875 | ||
| Convertible note | 560,620 | 559,790 | ||
| Trade payables | 118,922 | 103,678 | ||
| Other payables, lease liabilities and accrued expenses | 96,464 | 86,166 | ||
| Total current liabilities | 776,006 | 749,634 | ||
| Senior secured credit facility, net | 194,639 | 97,609 | ||
| Long-term leases | 42,682 | 42,853 | ||
| Employee benefit liabilities | 6,515 | 6,320 | ||
| Other long-term liabilities | 19 | 18 | ||
| Total long-term liabilities | 243,855 | 146,800 | ||
| Total liabilities | 1,019,861 | 896,434 | ||
| Ordinary shares no par value, unlimited shares authorized issued and outstanding 111,979,981 shares and 108,516,819 shares at september30, 2025 (unaudited) and december31, 2024, respectively | 0 | 0 | ||
| Additional paid-in capital | 1,612,997 | 1,583,138 | ||
| Accumulated other comprehensive income (loss) | -5,806 | -5,109 | ||
| Retained earnings (accumulated deficit) | -1,265,858 | -1,228,588 | ||
| Total shareholders' equity | 341,333 | 349,441 | ||
| Total liabilities and shareholders' equity | 1,361,194 | 1,245,875 | ||
NovoCure Ltd (NVCR)
NovoCure Ltd (NVCR)